Asahi Life Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Buy |
5,520
+140
| +3% | +$7.7K | 0.18% | 144 |
|
|
2025
Q1 | $380K | Buy |
+5,380
| New | +$380K | 0.25% | 104 |
|
|
2024
Q4 | – | Sell |
-5,470
| Closed | -$384K | – | 172 |
|
|
2024
Q3 | $384K | Buy |
+5,470
| New | +$384K | 0.23% | 113 |
|
|
2023
Q4 | – | Sell |
-3,500
| Closed | -$310K | – | 160 |
|
|
2023
Q3 | $310K | Buy |
3,500
+40
| +1% | +$3.54K | 0.11% | 115 |
|
|
2023
Q2 | $300K | Buy |
+3,460
| New | +$300K | 0.1% | 144 |
|
|
2021
Q4 | – | Sell |
-4,870
| Closed | -$376K | – | 196 |
|
|
2021
Q3 | $376K | Buy |
4,870
+20
| +0.4% | +$1.54K | 0.05% | 117 |
|
|
2021
Q2 | $405K | Buy |
4,850
+900
| +23% | +$75.2K | 0.05% | 112 |
|
|
2021
Q1 | $298K | Buy |
+3,950
| New | +$298K | 0.04% | 176 |
|